Emerging alphaviruses in the americas: Chikungunya and mayaro

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 47, Issue 6, 2014, Pages 677-683

  De Figueiredo, Mario Luis Garcia ^a,b   Figueiredo, Luiz Tadeu Moraes ^b  

^a INSTITUTO EVANDRO CHAGAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chikungunya fever; Emerging alphaviruses; Mayaro fever

Indexed keywords

ALPHA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ARTHRALGIA; ARTHROPATHY; ARTICLE; BACKACHE; CHIKUNGUNYA ALPHAVIRUS; COMMUNICABLE DISEASE; ENZYME IMMUNOASSAY; EYE PAIN; FEVER; GEOGRAPHIC DISTRIBUTION; HEADACHE; HUMAN; IMMUNE RESPONSE; IMMUNOFLUORESCENCE TEST; MAYARO VIRUS; MYALGIA; NONHUMAN; OPEN READING FRAME; POLYARTHRITIS; PROPHYLAXIS; RASH; REAL TIME POLYMERASE CHAIN REACTION; VIREMIA; VIRUS INFECTION; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS TRANSMISSION; ALPHAVIRUS; ALPHAVIRUS INFECTIONS; ANIMAL; CHIKUNGUNYA VIRUS; CLASSIFICATION; COMMUNICABLE DISEASES, EMERGING; DISEASE CARRIER; GENETICS; PHYSIOLOGY; VIROLOGY; WESTERN HEMISPHERE;

ALPHAVIRUS; ARBOVIRUS; CHIKUNGUNYA VIRUS; MAYARO VIRUS; TOGAVIRIDAE;

ALPHAVIRUS; ALPHAVIRUS INFECTIONS; AMERICAS; ANIMALS; CHIKUNGUNYA VIRUS; COMMUNICABLE DISEASES, EMERGING; HUMANS; INSECT VECTORS; VIRUS REPLICATION;

EID: 84921840700     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/0037-8682-0246-2014     Document Type: Article

References (50)

1. Koonin E. On the origin of cells and viruses: primordial virus world scenario. Ann NY Acad Sci 2009; 1178:47-64.
2. Figueiredo LT. Emergent arboviruses in Brazil. Rev Soc Bras Med Trop 2007; 40:224-229.
3. Pybus OG, Rambaut A. Evolutionary analysis of the dynamics of viral infectious disease. Nat Rev Genet 2009; 10:540-550.
4. Hamer DH, Chen LH. Chikungunya: Establishing a New Home in the Western Hemisphere. Ann Intern Med 2014; [Cited 2014 Oct]. Available at: http://annals.org/article.aspx?articleid=1906848/.
5. Abad-Franch F, Grimmer GH, Paula VS, Figueiredo LT, Braga WS, Luz SL. Mayaro virus infection in amazonia: a multimodel inference approach to risk factor assessment. PLoS Negl Trop Dis 2012; 26:1846.
6. Weaver SC, Reisen WR. Present and Future Arboviral Threats. Antiviral Res 2010; 85:328.
7. Arias-Goeta C, Moutailler S, Mousson L, Zouache K, Thiberge JM, Caro V, et al. Chikungunya virus adaptation to a mosquito vector correlates with only few point mutations in the viral envelope glycoprotein. Infect Genet Evol 2014; 24:116-126.
8. Paul D, Bartenschlager R. Architecture and biogenesis of plusstrand RNA virus replication factories. World J Virol 2013; 2:32-48.
9. Khan AH1, Morita K, Parquet Md Mdel C, Hasebe F, Mathenge EG, Igarashi A. Complete nucleotide sequence of chikungunya virus and evidence for an internal polyadenylation site. J Gen Virol 2002; 83:3075-3084.
10. Khan M, Dhanwani R, Kumar JS, Rao PV, Parida M. Comparative evaluation of the diagnostic potential of recombinant envelope proteins and native cell culture purifi ed viral antigens of Chikungunya virus. J Med Virol 2014; 86:1169-1175.
11. Jones KE, Patel NG, Levy MA, Storeygard D, Balk JL, et al. Global trends in emerging infectious diseases. Nature 2008; 451:990-994.
12. Pinheiro FP, Freitas RB, Rosa JFT, Gabbay YB, Mello WA, Le Duc JW. An outbreak of Mayaro virus disease in Belterra, Brazil. I. Clinical an virological fi ndings. Am J Trop Med Hyg 1981; 30:674-681.
13. Mourão MPG, Mota BR, Souza GS, Bastos MS, Gimaque JBL, Galusso ES, et al. Mayaro fever in Manaus, Brazil, 2007-2008. Vector Borne Zoonotic Dis 2012; 12:42-46.
14. Robinsonm C. An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-1953. I. Clinical features. Trans Royal Society Trop Med Hyg 1955, 49:28-32.
15. Schilte C, Couderc T, Chretien F, Sourisseau M, Gangneux N, Guivel-Benhassine F, et al. Type I IFN controls Chikungunya virus via its action on nonhematopoietic cells. J Exp Med 2010; 207: 429-442.
16. Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S. A single mutation in chikungunya virus affects vector specifi city and epidemic potential. PLoS Pathog 2007; 3:201.
17. Labadie K, Larcher T, Joubert C, Mannioui A, Delache B, Brochard P. Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J Clin Invest 2010; 120:894-906.
18. Kelvin AA, Banner D, Silvi G, Moro ML, Spataro N, Gaibani P, et al. Infl ammatory cytokine expression is associated with Chikungunya virus resolution and symptom severity. PLoS Negl Trop Dis 2011; 5:1279.
19. Dupuis-Maguiraga L, Noret M, Brun S, Le Grand R, Gras G, Roques P. Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia. PLoS Negl Trop Dis 2012; 6:1446.
20. Caglioti C, Lalle E, Castilletti C, Carletti F, Capobianchi MR, Bordi L. Chikungunya virus infection: an overview. New Microbiol 2013; 36:211-227.
21. Simon F, Javelle E, Oliver M, Leparc-Goffart I, Marimoutou C. Chikungunya Virus Infection. Curr Infect Dis Rep 2011; 13:218-228.
22. Kennedy AC, Fleming J, Solomon L. Chikungunya viral arthropathy: a clinical description. J Rheumatol 1980; 7:231-236.
23. Sam IC, Loong SK, Michael JC, Chua CL, Sulaiman WY, Vythillingam I, et al. Genotypic and phenotypic characterization of Chikungunya virus of different genotypes from Malaysia. PLoS One 2012; 7:50476.
24. Kalantri SP, Joshi R, Riley LW. Chikungunya epidemic: an Indian perspective. Natl Med J India 2006; 19:315-322.
25. Arias-Goeta C, Moutailler S, Mousson L, Zouache K, Thiberge JM, Caro V, et al. Chikungunya virus adaptation to a mosquito vector correlates with only few point mutations in the viral envelope glycoprotein. Infect Genet Evol 2014; 24:116-126.
26. World Health Organization. WHO report of outbreaks of Chikungunya 2005, 2006, 2007. WHO; 2007.
27. Center for Disease Control and Prevention (CDC). First Reports of Chikungunya in Western hemisphere. Press Release. CDC; 2007.
28. Fischer M, Staples JE, Arboviral Diseases Branch, National Center for Emerging and Zoonotic Infectious Diseases, Center for Disease Control and Prevention (CDC). Notes from the fi eld: chikungunya virus spreads in the Americas-Caribbean and South America, 2013-2014. MMWR Morb Mortal Wkly Rep 2014; 63:500-501.
29. Vega-Rúa A, Zouache K, Girod R, Failloux A, Lourenço-de-Oliveira R. High vector competence of Aedes aegypti and Aedes albopictus from ten American countries as a crucial factor of the spread of Chikungunya. J Virol 2014; [Cited 2014 October]. Available at: http://jvi.asm.org/content/early/2014/03/20/JVI.00370-14.short/.
30. Gallian P, Lamballerie X, Salez N, Piorkowski G, Richard P, Paturel L, et al. Prospective detection of chikungunya virus in blood donors, Caribbean 2014. Blood 2014; 123:3679-3681.
31. Pan American Health Organization (PAHO). Chikungunya outbreaks. PAHO; 2014.
32. Ministério da Saúde. Boletins sobre Chikungunya, 2001-2014. Brasília: Ministério da Saúde; 2014.
33. Anderson CR, Downs WG, Wattley GH, Ahin NH, Reese AA. Mayaro virus: a new human disease agent. II Isolation from blood of patients in Trinidad. Am J Trop Med Hyg 1957; 6:1012-1016.
34. Powers AM, Aguilar PV, Chandler LJ, Brault AC, Meakins TA, Watts D, et al. Genetic relationships among Mayaro and Una viruses suggest distinct patterns of transmission. Am J Trop Med Hyg 2006; 75:461-469.
35. Figueiredo LTM, Nogueira RMR, Cavalcanti SMB, Rosa AT, Schatzmayr H. Study of two different enzyme immunoassays for the detection of Mayaro virus antibodies. Mem Inst Oswaldo Cruz 1989; 84:303-307.
36. Coimbra TL, Santos CL, Suzuki A, Petrella SM, Bisordi I, Nagamori AH, et al. Mayaro virus: imported cases of human infection in São Paulo State, Brazil. Rev Inst Med Trop Sao Paulo 2007; 49:221-224.
37. Bronzoni RVM, Moreli ML, Cruz ACR, Figueiredo LTM. Multiplex-nested-PCR for Brazilian Alphavirus diagnosis. Trans R Soc Trop Med Hyg 2004; 98:456-461
38. Bronzoni RVM, Nogueira RMR, Nunes M, Figueiredo LTM. Detection and identifi cation of Brazilian alphaviruses and fl aviviruses by multiplex RT-PCR. J Clin Microbiol 2005; 43:696-702.
39. Figueiredo LT, Maciel MAV, Shope R. Identifi cation of viruses, Togaviridae, Alphavirus: identifi cation of Chikungunya virus from Central African Republic. Annual Report for 1986. Yale Arbovirus Research Unit-International Center for Arboviruses 1986; 1986:25-26.
40. Figueiredo LTM. Togaviridae-Alphavirus. In: Oliveira LHS, editor. Virologia Humana. Rio de Janeiro: Cultura Médica; 1994. p. 213-222.
41. Greiser-Wilke I, Moennig V, Kaaden O, Figueiredo LTM. Most alphaviruses share a conserved epitopic region on their nucleocapsid protein. Journal General Virol 1989; 70:743-748.
42. Yap G, Pok KY, Lai YL, Hapuarachchi HC, Chow A, Leo YS, et al. Evaluation of Chikungunya diagnostic assays: differences in sensitivity of serology assays in two independent outbreaks. PLoS Negl Trop Dis 2010; 4:753.
43. Taubitz W, Cramer JP, Kapaun A, Pfeffer M, Drosten C, Dobler G, et al. Chikungunya fever in travelers: clinical presentation and course. Clin Infect Dis 2007; 45:1-4.
44. Brighton SW. Chloroquine phosphate treatment of chronic Chikungunya arthritis: an open pilot study. S Afr Med J 1984; 66:217-218.
45. Ravichandran R, Manian M. Ribavirin therapy for Chikungunya arthritis. J Infect Dev Ctries 2008; 2:140-142.
46. Briolant S, Garin D, Scaramozzino N, Jouan A, Crance JM. In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-alpha and ribavirin combination. Antiviral Res 2004; 61:111-117.
47. Dessain SK, Adekar SP, Berry JD. Exploring the native human antibody repertoire to create antiviral therapeutics. Curr Top Microbiol Immunol 2008; 317:155-183.
48. Couderc T, Khandoudi N, Grandadam M, Visse C, Gangneux N, Bagot S, et al. Prophylaxis and therapy for Chikungunya virus infection. J Infect Dis 2009; 200:516-523.
49. Chang LJ, Dowd KA, Mendoza FH, Saunders JG, Sitar S, Plummer SH, et al. The VRC 311 Study Team. Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial. Lancet 2014; [Cited 2014 October]. Available at: http://www. thelancet.com/journals/lancet/article/PIIS0140-6736 (14) 61185-5?abstract/.
50. Weise WJ, Hermance ME, Forrester N, Adams AP, Langsjoen R, Gorchakov R, et al. A novel live-attenuated vaccine candidate for mayaro Fever. PLoS Negl Trop Dis 2014; 8:2969.